Cita APA (7a ed.)

Metts, J., Bradley, H. L., Wang, Z., Shah, N. P., Kapur, R., Arbiser, J. L., & Bunting, K. D. (2017). Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells. Nature Portfolio.

Cita Chicago Style (17a ed.)

Metts, Jonathan, Heath L. Bradley, Zhengqi Wang, Neil P. Shah, Reuben Kapur, Jack L. Arbiser, y Kevin D. Bunting. Imipramine Blue Sensitively and Selectively Targets FLT3-ITD Positive Acute Myeloid Leukemia Cells. Nature Portfolio, 2017.

Cita MLA (8a ed.)

Metts, Jonathan, et al. Imipramine Blue Sensitively and Selectively Targets FLT3-ITD Positive Acute Myeloid Leukemia Cells. Nature Portfolio, 2017.